STOCK TITAN
  1. Home
  2. News
  3. AXSM

Axsome Therapeutics Inc - AXSM STOCK NEWS

IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
conferences
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
conferences
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
earnings
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics and the Global Alzheimer’s Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer’s Disease Awareness Month 2023
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics to Present at Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
clinical trial
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
management
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
conferences earnings
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day
IMPACT
SENTIMENT
AXSM : Nasdaq
Axsome Therapeutics to Present at Three Upcoming Investor Conferences
conferences
Stock AXSM logo
Axsome Therapeutics Inc

Nasdaq:AXSM

AXSM Rankings

#1812 Ranked by Market Cap
#550 Ranked by Stock Gains
N/A Ranked by Dividends

AXSM Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
New York

About AXSM

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.